Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Exchange Rate Effect (2019 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Exchange Rate Effect for 7 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect fell 41.37% year-over-year to $1.3 million, compared with a TTM value of $1.6 million through Dec 2025, up 28.34%, and an annual FY2025 reading of $1.6 million, up 28.34% over the prior year.
  • Exchange Rate Effect was $1.3 million for Q4 2025 at Tandem Diabetes Care, up from $605000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $2.2 million in Q4 2024 and bottomed at -$1.9 million in Q1 2025.
  • Average Exchange Rate Effect over 5 years is $181800.0, with a median of $22000.0 recorded in 2021.
  • The sharpest move saw Exchange Rate Effect tumbled 3200.0% in 2022, then skyrocketed 14600.0% in 2023.
  • Year by year, Exchange Rate Effect stood at $103000.0 in 2021, then skyrocketed by 903.88% to $1.0 million in 2022, then tumbled by 57.45% to $440000.0 in 2023, then surged by 392.27% to $2.2 million in 2024, then tumbled by 41.37% to $1.3 million in 2025.
  • Business Quant data shows Exchange Rate Effect for TNDM at $1.3 million in Q4 2025, $605000.0 in Q3 2025, and $1.6 million in Q2 2025.